Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07699601
PHASE2/PHASE3

Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery

Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

This clinical trial is a multiple-center, randomized, double-blind, placebo- and active-controlled parallel-group Phase II/III clinical trial, to evaluate the efficacy and safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery.

Official title: A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Parallel-Group Phase II/III Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablets for Postoperative Analgesia in Orthopedic Surgery

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

330

Start Date

2026-05-09

Completion Date

2026-12

Last Updated

2026-07-13

Healthy Volunteers

No

Interventions

DRUG

HL-1186

HL-1186 tablet for oral administration.

DRUG

HL-1186 placebo

HL-1186 placebo tablet for oral administration.

DRUG

Oxycodone-Acetaminophen

Oxycodone-Acetaminophen for oral adminstration

DRUG

Oxycodone-Acetaminophen Matching Placebo

Oxycodone-Acetaminophen Matching Placebo for oral adminstration

Locations (1)

The Third Xiangya Hospital of Central South University, Changsha, Hunan

Changsha, Hunan, China